Discovery of the Clinical Candidate S‑892216: A Second-Generation of SARS-CoV‑2 3CL Protease Inhibitor for
AI in drug design: evolution or revolution? Darren sets out to explore the impact
One Chiral Fingerprint To Find Them All Markus Orsi & Jean-Louis Reymond. J. Cheminform.,
Identification of Novel, Selective Ataxia-Telangiectasia Mutated Kinase Inhibitors with the Ability to Penetrate the
The First ATP Competitive Type-III c-MET Inhibitor? In this paper, the target was c-MET,
Where Old Meets New: Advancements in AlphaFold with Some Help From Boltzmann With
Fast calculation of hydrogen-bond strengths and free energy of hydration of small molecules For
Discovery of the Potent and Selective MC4R Antagonist PF-07258669 for the Potential Treatment of
MCPairs v1.9 release is automatically available to all users: MCPairs version 1.9 went live
Med Chem Paper of the Month – Jan/Feb 2023 This paper is a fine exhibition
There are two parts to our business – Software and Consulting. Get in touch today to find out how we can help you save time and money.
© 2026 MedChemica • All rights reserved.
41 Avada Avenue, Florida, 98765
403-904-3623
